As of 2025-11-13, the Intrinsic Value of Poolbeg Pharma PLC (POLB.L) is -3.93 GBP. This POLB.L valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.65 GBP, the upside of Poolbeg Pharma PLC is -207.76%.
Based on its market price of 3.65 GBP and our intrinsic valuation, Poolbeg Pharma PLC (POLB.L) is overvalued by 207.76%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.93 - -3.93 | -3.93 | -207.76% |
| P/E | (15.26) - (15.31) | (14.59) | -499.8% |
| DDM - Stable | (4.54) - (9.47) | (7.00) | -291.9% |
| DDM - Multi | (3.93) - (6.41) | (4.88) | -233.6% |
| Market Cap (mil) | 26.49 |
| Beta | 0.27 |
| Outstanding shares (mil) | 7.26 |
| Enterprise Value (mil) | 16.53 |
| Market risk premium | 5.98% |
| Cost of Equity | 13.80% |
| Cost of Debt | 5.00% |
| WACC | 9.34% |